Welcome to the Ulipristal Pregnancy RegistryThis pregnancy registry is a joint initiative and is developed by the following pharmaceutical companies:
- Aristo Pharma GmbH
- Aspen Healthcare Malta Limited
- ELPEN Pharmaceutical Co. Inc
- Eugia Pharma (Malta) Ltd.
- Exeltis Pharmaceuticals Holding, S.L.
- Farmitalia s.r.l
- HELM AG
- Hexal AG
- STADA Arzneimittel AG
- Zentiva Group, a.s.
This pregnancy registry is aimed at collecting medical data about pregnancy outcomes in women exposed to Ulipristal 30 mg.
If you are a woman who used ulipristal 30 mg at any time during pregnancy or used ulipristal 30 mg during the menstrual cycle in which a pregnancy started and want to obtain general information on the pregnancy registry and access the on-line questionnaire, please click on ‘Woman’ below. Woman
If you are a health care provider, please click on 'Health Care Provider' below to read information on this registry and access the on-line questionnaire. Health Care Provider